China Diagnostic Reagent Industry Report, 2013-2015
  • Oct./2013
  • Hard Copy
  • USD $2,200
  • Pages:81
  • Single User License
    (PDF Unprintable)       
  • USD $2,100
  • Code: ZYM049
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,300
  • Hard Copy + Single User License
  • USD $2,400
      
Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented the CAGR of over 15%, hitting RMB13.3 billion with the year-on-year growth rate of 16.7% in 2012. Moreover, the market will accelerate its pace in the wake of China’s medical reform, enhanced health awareness of people and improved physical examination technology. ?

Chinese In Vitro Diagnostic Reagent Market Size and YoY Growth Rate
20130277.png

In China, in vitro diagnostic reagents consist of biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and hematology diagnostic reagents. Biochemical and immune diagnostic reagents enjoyed the highest 70% market share together in 2012, which was determined by the domestic medical demand. Chinese economy and the government medical expenditure stay at a low level, which affects the medical diagnosis consumption seriously.

From now to the next three years, China will desire regular tests mostly, which have the most demand for biochemical and immune diagnostic reagents. The progress in Chinese diagnosis technology and the increase of high-end consumers will boost the demand for molecular diagnostic reagents and other related reagents. The demand for biochemical and immune diagnostic reagents will occupy 60% in 2015.

By virtue of high performance-price ratio and local advantages, Chinese diagnostic reagent enterprises have broken through the monopolization of foreign brands. However, foreign companies still seize 30-40% market share in China with the technical advantages in medium- and high-end fields as well as the monopoly on “instrument + reagent” integrated platforms.

In China, there are 300-400 diagnostic reagent enterprises, including the leaders KHB, Da An Gene, Sinocare and Leadman, but their market share was still as low as 3.4%, 2.4%, 2.1% and 2.0% respectively in 2012.

The report mainly includes the followings:

20120114.gif Status quo, market segments, import and export, competition pattern and profitability of Chinese diagnostic reagent market;
20120114.gif Development trends of Chinese diagnostic reagent in terms of policies (including medical reform), population structure and detection technology;
20120114.gif Operation, diagnostic reagent business and prospect of 11 companies, such as KHB, Da An Gene, Sinocare, Leadman, BioSino Bio-technology and Science.

1 Overview of Diagnostic Reagent Industry
1.1 Definition 
1.2 Classification
1.3 Industry Chain

2 Status Quo of China Diagnostic Reagent Industry
2.1 Overview
2.2 Market Structure
2.3 Import and Export
2.3.1 Import
2.3.2 Export
2.4 Competition Pattern
2.5 Market Segments
2.5.1 Biochemical Diagnostic Reagents
2.5.2 Immunodiagnostic Reagents
2.5.3 Molecular Diagnostic Reagent
2.5.4 Comprehensive In Vitro Diagnostic Reagents
2.6 Profit Level

3 Development Forecast of China Diagnostic Reagent Industry
3.1 Overall Forecast  
3.1.1 The release of a number of favorable policies is conducive to the development of the diagnostic reagent industry
3.1.2 Large population base and enhanced aging promote the growth of the diagnostic reagent market
3.1.3 The government's medical and health expenditure keeps increasing
3.1.4 The number of outpatients maintains stable growth
3.1.5 Great Development Potentials of Detectable Items
3.1.6 Market Scale Forecast
3.2 Development Trends of Diagnostic Reagent Industry 
3.2.1 Biochemical Diagnosis and Immunodiagnosis Will Still Be the Mainstream
3.2.2 Industry Concentration Will Increase
3.2.3 Enterprises with Complete Product Line Integrating Reagents and Instruments will Win

4 Major Chinese Diagnostic Reagent Enterprises 
4.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB)
4.1.1 Profile 
4.1.2 Operation 
4.1.3 Revenue Structure 
4.1.4 Gross Margin 
4.1.5 R & D and Investment  
4.1.6 Clients 
4.1.7 In Vitro Diagnostics Business
4.1.8 Forecast and Prospect 
4.2 Da An Gene Co., Ltd.
4.2.1 Profile 
4.2.2 Operation 
4.2.3 Revenue Structure 
4.2.4 Gross Margin 
4.2.5 Clients and Suppliers 
4.2.5 R & D and Investment  
4.2.6 Diagnostic Reagent Business 
4.2.7 Forecast and Prospect 
4.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
4.3.1 Profile 
4.3.2 Operation 
4.3.3 Revenue Structure 
4.3.4 Gross Margin 
4.3.5 R & D and Investment  
4.3.6 Diagnostic Reagent Business 
4.3.7 Forecast and Prospect
4.4 BioSino Bio-technology and Science Inc.
4.4.1 Profile 
4.4.2 Operation 
4.4.4 R & D and Investment  
4.4.5 Forecast and Prospect 
4.5 Beijing Kinghawk Pharmaceutical Co., Ltd.
4.5.1 Profile 
4.5.2 Operation 
4.5.3 Revenue Structure 
4.5.4 Gross Margin 
4.5.5 Forecast and Prospect 
4.6 Livzon Pharmaceutical Group Inc.
4.6.1 Profile 
4.6.2 Operation 
4.6.3 Revenue Structure 
4.6.4 Gross Margin 
4.6.5 Diagnostic Reagent Business 
4.6.6 Forecast and Prospect 
4.7 Beijing Leadman Biochemistry Co., Ltd.
4.7.1 Profile 
4.7.2 Operation 
4.7.3 Revenue Structure 
4.7.4 Gross Margin 
4.7.5 R & D and Investment  
4.7.6 Clients 
4.7.7 Forecast and Prospect 
4.8 Changsha Sinocare Inc.
4.8.1 Profile 
4.8.2 Operation 
4.8.3 Revenue Structure 
4.8.4 Gross Margin 
4.8.5 R & D and Investment  
4.8.6 Development Forecast 
4.9 Bohui Innovation Technology Co., Ltd.
4.9.1 Profile 
4.9.2 Operation 
4.9.3 Revenue Structure 
4.9.4 Gross Margin 
4.9.5 R & D and Investment  
4.9.6 Clients 
4.9.7 Development Forecast 
4.10 Others
4.10.1 Shinva Group 
4.10.2 Humanwell Healthcare 
Major In Vitro Diagnostic Reagent Types (by Test Principle or Method)
In Vitro Diagnostic Reagent Types and Products (by National Policy)
Diagnostic Reagent Industry Chain
Revenue of China Biological Product Industry, 2005-2012
Chinese In Vitro Diagnostic Reagent Market Size, 2007-2013
Chinese In Vitro Diagnostic Reagent Market Structure, 2012
China's Diagnostic Reagent Import Volume, 2008-2013
China's Diagnostic Reagent Import Value, 2008-2013
China's Diagnostic Reagent Import Price, 2008-2013
China's Diagnostic Reagent Import Volume and Value by Country or Region, 2012-1013
China's Diagnostic Reagent Export Volume, 2008-2013
China's Diagnostic Reagent Export Value, 2008-2013
China's Diagnostic Reagent Export Price, 2007-2013
Top 10 Export Destinations of Chinese Diagnostic Reagents by Export Volume and Value, 2012-2013
Diagnostic Instrument Contrast between Domestic and Foreign Enterprises
Competition Pattern of China Diagnostic Reagent Industry
Revenue and Market Share of Some Chinese In Vitro Diagnosis Companies, 2012
IVD Gross Margin of Some Chinese Diagnostic Reagent Companies, 2008-2013
Major Policies of China Diagnostic Reagent Industry, 2010-2013
Population of 65-year-old People and Proportion in Total Population in China, 1982-2012
Two-week Prevalence Rate of People at All Ages in China
Total Medical & Health Costs and Proportion in GDP in China, 1980-2012
Chinese Medical & Health Cost Structure, 2008-2011
Number of Hospitals in China, 2005-2013
Number of Hospitals in China (by Grade), 2012
Diagnoses of Chinese Hospitals, 2005-2013
Chinese In Vitro Diagnostic Reagent Market Size, 2012-2015E
In Vitro Diagnostic Reagent Product Structure in China, 2015E
Products and Revenue of Major Global Diagnostic Reagent Companies
Development Process of Roche Diagnostics
Integrated Development Strategy of Global Leading Diagnostic Reagent Companies
KHB’s Revenue and Net Income, 2008-2013 
KHB’s Operating Revenue (by Product), 2008-2013 
KHB’s Operating Revenue (by Region), 2010-2013  
KHB’s Gross Margin (by Product), 2008-2013   
R&D Costs and % of Total Revenue of KHB, 2008-2012
KHB’s New Products, by Jul 2013 
KHB’s Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Name List and Revenue Contribution of KHB’s Top 5 Clients, 2012-2013
Name List and Procurement of KHB’s Top 5 Suppliers, 2012
KHB’s Diagnostic Reagent Revenue Structure, 2012
KHB’s Medical Instrument Types and Products, 2012
KHB’s Revenue and Net Income, 2012-2015E 
Revenue and Profit of Da An Gene, 2008-2013     
Operating Revenue of Da An Gene (by Product), 2008-2013  
Revenue Structure of Da An Gene (by Region), 2008-2013
Gross Margin of Da An Gene (by Product), 2008-2013 
Name List and Revenue Contribution of Top 5 Clients of Da An Gene, 2012-2013
Name List and Procurement of Top 5 Suppliers of Da An Gene, 2012
R&D Costs and % of Total Revenue of Da An Gene, 2010-2012
Reagent Revenue and Gross Margin of Da An Gene, 2008-2013
Instrument Revenue and Gross Margin of Da An Gene, 2008-2013
Principal Assets and Business of Da An Gene
Industrial Chain Layout of Da An Gene
Revenue and Net Income of Da An Gene, 2012-2015E 
Revenue and Net Income of Fosun Pharmaceutical, 2008-2013 
Operating Revenue of Fosun Pharmaceutical (by Product), 2008-2013
Revenue of Fosun Pharmaceutical (by Region), 2008-2013   
Gross Margin of Fosun Pharmaceutical (by Product), 2008-2013   
R&D Costs and % of Total Revenue of Fosun Pharmaceutical, 2008-2013
Revenue and Net Income of Fosun Pharmaceutical, 2012-2015E 
Revenue and Annual Profit of BioSino Bio-technology and Science, 2008-2013 
R&D Costs and % of Total Revenue of BioSino Bio-technology and Science, 2008-2013 
Revenue and Profit of BioSino Bio-technology and Science, 2012-2015E  
Revenue and Net Income of Kinghawk Pharmaceutical, 2008-2013 
Revenue of Kinghawk Pharmaceutical (by Product), 2010-2013
Gross Margin of Kinghawk Pharmaceutical (by Product), 2010-2012    
Revenue and Net Income of Kinghawk Pharmaceutical, 2012-2015E 
Livzon’s Revenue and Net Income, 2008-2012 
Livzon’s Operating Revenue (by Product), 2008-2013 
Livzon’s Revenue (by Region), 2008-2013
Livzon’s Gross Margin (by Product), 2008-2013   
Major Diagnostic Reagent Products of Livzon
Revenue and Gross Margin of Livzon’s Diagnostic Reagent and Equipment, 2008-2013
Livzon’s Revenue and Net Income, 2012-2015E 
Leadman’s Revenue and Net Income, 2008-2013 
Leadman’s Operating Revenue (by Product), 2008-2013
Leadman’s Operating Revenue (by Region), 2011-2013
Leadman’s Gross Margin (by Product), 2008-2013
R&D Costs and % of Total Revenue of Leadman, 2008-2013
Leadman’s Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Name List and Revenue Contribution of Leadman’s Top 5 Clients, 2012-2013 
Number of Leadman’s Dealers, 2008-2012   
Leadman’s Revenue and Net Income, 2012-2015E 
Sinocare’s Revenue and Net Income, 2009-2013 
Sinocare’s Capacity, Output and Sales Volume, 2009-2011 
Sinocare’s Blood Sugar Testing Instrument and Strip Sales Price (by Type), 2009-2011
Sinocare’s Operating Revenue (by Product), 2009-2013 
Sinocare’s Revenue (by Region), 2009-2013       
Sinocare’s Gross Margin (by Product), 2009-2011
R&D Costs and % of Total Revenue of Sinocare, 2010-2013
Revenue and Net Income of Sinocare, 2012-2015E 
Revenue and Net Income of Bohui Innovation, 2010-2013 
Output, Sales Volume and Inventory of Bohui Innovation, 2011-2012
Revenue of Bohui Innovation (by Product), 2010-2013 
Gross Margin of Bohui Innovation (by Product), 2010-2013 
R&D Costs and % of Total Revenue of Bohui Innovation, 2010-2013
Fund-raising Projects and Capacity of Bohui Innovation  
Name List, Revenue Breakdown and Percentage of Clients of Bohui Innovation, 2012-2013 
Revenue and Net Income of Bohui Innovation, 2012-2015E      
Revenue and Net Income of Shinva, 2008-2012 
Revenue and Profit of Humanwell Healthcare, 2007-2013   

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号